Neuroimmune Empowerment Network gives patients and families resources to advocate for themselves and their loved ones! Following payment, please expect to receive an email with login information within five business days.
About the Impact Circle: Neuroimmune Empowerment Network
The Impact Circle: Neuroimmune Empowerment Network is an impact driven membership program designed to empower patients and families by providing access to high quality content designed for for researchers and clinicians treating patients with complex conditions including PANS, inflammatory brain disorders, encephalitis, and immune-mediated neuropsychiatric deteriorations, including those occurring in patients with autism.
Though designed for clinicians, we recognize many patients and families seek access to high quality content designed for clinicians so that they can best advocate for themselves and their loved ones, so we created the Impact Circle: Neuroimmune Empowerment Network for patients and families.
Neuroimmune Impact Circle members are dedicated core members of the neuroimmune community who receive exclusive benefits, including access to:
- Live Q&As with highly regarded experts in the field
- Exclusive access to premium content, including recordings from CME events
- Steep discounts for CME events, including the Inflammatory Brain Disorders Conference
- Priority registration to events
- Quarterly compilation of relevant new research
- Quarterly opportunities to provide feedback that will guide Impact Circle activities
Neuroimmune Impact Circle revenue supports our mission to scale educational outreach to clinicians worldwide, offering free and affordable accredited Continuing Medical Education, and developing and supporting capacity-building initiatives to expand patient access to care.
Impact Circle – Neuroimmune Empowerment Network aims to:
- Keep members apprised of the latest research, treatment, and clinical advances so they can best advocate for themselves and their family members.
- Create a sense of community amongst members.
Upcoming Live Events For Impact Circle Members
These live Q&As are open to Impact Circle members only. There is no fee for Impact Circle members to attend but registration is required.
Mark Pasternack, MD
(click photo for biography)
Q&A – November 5, 2024
4:00 pm PT, 7:00 ET
QA focus: Infections in PANS/PANDAS
Jennifer Frankovich, MD
(click photo for biography)
Q&A – December 3, 2024
4:00 pm PT, 7:00 ET
QA focus: PANS, autoimmune and immune conditions
Shannon Delaney, MD
(click photo for biography)
Q&A – December 12, 2024
4:00 pm PT, 7:00 ET
QA focus: PANS/PANDAS, Lyme, Tick-borne Illnesses
Jennifer Frankovich, MD
(click photo for biography)
Q&A – February 4, 2025
4:00 pm PT, 7:00 ET
QA focus: PANS, autoimmune and immune conditions
Inflammatory Brain Disorders Conference 2025
Impact Circle Members: discounted registration is not yet opened, however, all individuals who become members by November 13, 2024 will be eligible for discounted conference registration.
Discounted registration is not yet open. You will receive an email when it opens and will have one month to register for the conference at that point. Please note that if you do not remain up to date on your payments and there is a lapse in payment at any point prior to the conference, you will no longer be eligible for discounted registration.
Recordings currently available (updated quarterly)
Single Lectures
Ming Lim, MD, PhD
Professor, Paediatric Neurology, King’s College London, HOS Children’s Neuroscience, Consultant Paediatric Neurologist, Children’s Neuroscience Centre, Evelina London Children’s Hospital, King’s Health Partners Academic Health Science Centre
Atypical Presentations of Autoimmune Encephalitis
Karen Parker, PhD (Keynote)
Professor, Department of Psychiatry & Behavioral Sciences; Principal Investigator, Social Neurosciences Research Program; Chair, Psychiatry Major Laboratories Steering Committee; Associate Chair, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine
Vasopressin: A Robust Biomarker and Promising Therapeutic for Autism
Douglas Wallace, MD, PhD
Michael and Charles Barnett Endowed Chair in Pediatric Mitochondrial Medicine and Metabolic Disease; Director, Center for Mitochondrial and Epigenomic Medicine, The Children’s Hospital of Philadelphia; Professor, Department of Pediatrics, Division of Human Genetics Perelman School of Medicine, University of Pennsylvania
A Mitochondrial Etiology of Autism and Associated Neuropsychiatric Disorders
Terry Harville, MD, PhD
Professor of Pathology and Laboratory Services, and Internal Medicine; Medical Director, HLA and Histocompatibility Laboratory; Medical Director, Immunogenetics and Transplantation Laboratory; Medical Director UAMS ABG Laboratory, The University of Arkansas for Medical Sciences
Case Presentations of the Spectrum of ASD
Ben Marlow, MBBS, MRCPCH, PGCME
Consultant Paediatrician (Neurodevelopment) ESNEFT; Clinical Director – The Synapse Centre for Neurodevelopment; Clinical Lead for Paediatrics SNEE ICB; Visiting Senior Lecturer Anglia Ruskin School of Medicine
Sleep Difficulties in Autism: Investigation and Management Strategies
Lectures with multiple speakers
Infection and Inflammation Related Neuropsychiatric Deteriorations in Youth with Autism: Case Presentations by The Stanford Immune Behavioral Health Team
Jennifer Frankovich, MD, MS
Clinical Professor of Pediatrics, Rheumatology, Stanford University School of Medicine; Director, Stanford PANS Research Program
Meiqian Ma, MD
Clinical Assistant Professor, Pediatrics – Rheumatology Stanford University School of Medicine
Melissa Silverman, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences – Child and Adolescent Psychiatry and Child Development, Stanford University School of Medicine
Bahare Farhadian, MSN, RN, FNP-C
Rheumatology – Family Nurse Practitioner, Stanford Medicine Children’s Health